Education
About Us
Working with TipRanks
Follow Us
Croda International PLC (GB:CRDA)
LSE:CRDA
CRDA Stock Chart & Stats
2767.00 p
11.00 p(0.34%)
At close: 4:00 PM EST
2767.00 p
11.00 p(0.34%)
Day’s Range― - ―
52-Week Range2,426.77 p - 3,324.00 p
Previous CloseN/A
Volume8.09K
Average Volume (3M)650.08K
Market Cap
£3.86B
Enterprise Value4.45B
Total Cash (Recent Filing)£172.80M
Total Debt (Recent Filing)£760.30M
Price to Earnings (P/E)60.7
Beta1.32
Next Earnings
Jul 29, 2026EPS Estimate
0.76Next Dividend Ex-DateN/A
Dividend Yield3.45%
Share Statistics
EPS (TTM)0.74
Shares Outstanding139,635,440
10 Day Avg. Volume610,745
30 Day Avg. Volume650,080
Financial Highlights & Ratios
PEG Ratio-0.99
Price to Book (P/B)1.72
Price to Sales (P/S)2.21
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£3,278.00Price Target Upside18.47% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)1.56
Revenue Forecast (FY)£1.74B
Bulls Say, Bears Say
Bulls Say
High-margin Specialty Mix & Niche MarketsCroda’s shift to high-value end markets (consumer, pharma, agriculture) and growth in patented ingredients creates durable product differentiation and customer stickiness. Specialized formulation inputs and improved NPS support premium pricing, reducing reliance on commoditized volumes over the medium term.
Solid Cash Generation And Improving LeverageConsistent operating cash flow and a tangible FCF uptick in 2025 strengthen financial flexibility to fund transformation, capex and dividends. Lower net debt and sub-1.5x leverage provide headroom for selective investment while limiting refinancing risk over the next 2–4 years.
Clear Transformation Targets And Management PlanManagement has set measurable 2028 targets (margin >20%, FCF conversion >12%, £100m savings) and delivered early recurring savings. This structured program, if executed, can sustainably lift margins and ROIC, improving long-term profitability and cash conversion.
Bears Say
Large Exceptional Impairments And RestructuringSubstantial non‑cash impairments and ongoing restructuring signal past capacity or allocation missteps and raise the risk of further write‑downs. They depress reported earnings and indicate execution/portfolio-optimization costs that can weigh on investor returns and complicate near-term recovery.
Segment Volatility: Pharma Solutions & Industrial SpecialtiesCore segments show uneven performance: Pharma faces policy-driven volatility and IS has material volume sensitivity (large Cargill exposure). Such end-market and customer-concentration swings reduce revenue visibility and make margin recovery contingent on stabilizing demand and winning share in niches.
Revenue And Profitability Normalization; Compressed ReturnsAfter a 2021–22 step-up, sales and earnings reverted lower and ROE sits in mid-single digits. Lower profitability and volatile top-line growth limit balance-sheet compounding and make delivery of higher ROIC and sustained dividend policy dependent on successful execution of efficiency and growth initiatives.
Croda International News
CRDA FAQ
What was Croda International PLC’s price range in the past 12 months?
Croda International PLC lowest share price was 2426.77 p and its highest was 3324.00 p in the past 12 months.
What is Croda International PLC’s market cap?
Croda International PLC’s market cap is £3.86B.
When is Croda International PLC’s upcoming earnings report date?
Croda International PLC’s upcoming earnings report date is Jul 29, 2026 which is in 142 days.
How were Croda International PLC’s earnings last quarter?
Croda International PLC released its earnings results on Feb 24, 2026. The company reported 0.74 p earnings per share for the quarter, beating the consensus estimate of 0.684 p by 0.056 p.
Is Croda International PLC overvalued?
According to Wall Street analysts Croda International PLC’s price is currently Undervalued.
Does Croda International PLC pay dividends?
Croda International PLC pays a Semiannually dividend of 48 p which represents an annual dividend yield of 3.45%. See more information on Croda International PLC dividends here
What is Croda International PLC’s EPS estimate?
Croda International PLC’s EPS estimate is 0.76.
How many shares outstanding does Croda International PLC have?
Croda International PLC has 139,635,440 shares outstanding.
What happened to Croda International PLC’s price movement after its last earnings report?
Croda International PLC reported an EPS of 0.74 p in its last earnings report, beating expectations of 0.684 p. Following the earnings report the stock price went up 7.605%.
Which hedge fund is a major shareholder of Croda International PLC?
Currently, no hedge funds are holding shares in GB:CRDA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Croda International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£3,278.00 (18.47% Upside)
£3,278.00 (18.47% Upside)
Blogger Sentiment
Bullish
GB:CRDA Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth £20.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.88%
12-Months-Change
Fundamentals
Return on Equity
6.17%
Trailing 12-Months
Asset Growth
-3.21%
Trailing 12-Months
Company Description
Croda International PLC
Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. It operates through four segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The company offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries. It also provides specialty ingredients for self-tanning, color cosmetics, bath and shower, deodorants, anti-perspirants, depilatories, men's grooming, and oral hygiene, as well as skin, hair, sun, body, and baby care applications; construction chemicals and bitumen additives; dietary supplements; and materials and polymer additives for electronics and devices. In addition, the company offers chemistries, emulsifiers, fuel and power generation additives, and polymer additives; food additives; specialty polymer additives for furniture and wood applications; household, industrial, and institutional cleaning products; lubricants; oleochemicals; and packaging, print, and paper chemicals. Further, it provides paints and coatings; active pharmaceutical ingredients; thermal management products; plastic and rubber products; skin health products; hygiene and industrial nonwovens, botanical extracts, tissues, and textile auxiliaries; and water treatment chemicals. Additionally, the company offers bio-based phase change materials for buildings and ventilation, clothing and healthcare, electronics and devices, food and refrigeration, energy storage and recovery, temperature controlled packaging, and vehicles and automotive applications. The company was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
CRDA Stock 12 Month Forecast
Average Price Target
3,278.00 p
▲(18.47% Upside)
Technical Analysis
Options Prices
Currently, No data available
---